Kura Oncology, Inc.
KURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$174 | -$153 | -$136 | -$130 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $5 |
| Stock-Based Comp. | $34 | $28 | $26 | $24 |
| Change in WC | $286 | $8 | -$3 | -$3 |
| Other Non-Cash | -$13 | -$9 | $2 | $0 |
| Operating Cash Flow | $134 | -$125 | -$110 | -$105 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | -$659 | -$410 | -$271 | -$446 |
| Inv. Sales/Matur. | $558 | $426 | $304 | $320 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | -$102 | $16 | $33 | -$127 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $10 | -$7 |
| Stock Issued | $146 | $94 | $25 | $4 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $1 | $4 | -$1 |
| Financing Cash Flow | $154 | $95 | $39 | -$3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $187 | -$14 | -$39 | -$235 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $52 | $91 | $326 |
| End Cash | $224 | $37 | $52 | $91 |
| Free Cash Flow | $134 | -$125 | -$111 | -$106 |